FDA Recall United States Terminated Historical recordClass I
ADM - CHICAGO
- Product
- Miss Minneapolis Product Code: 803003 Bulk flour
- Reason
- potential presence of E. coli. O26
- Published
- July 24, 2019
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.
37,139
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,799
Class I recallsReasonable probability of serious health consequences24,349
Class II recallsTemporary or medically reversible health consequences2,891
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/deanos-pasta-issue-allergy-alert-undeclared-lobster-pear-and-pecorino-triangoli-ravioliPublished September 24, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,527 recalls have been announced year to date.
- Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
- The highest complete period was Jun 2026 (297).
- Sep 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,349 |
| Class I | 9,799 |
| Class III | 2,891 |
| Not Yet Classified | 1 |
| Class | Recalls |
|---|---|
| Class II | 24,349 |
| Class I | 9,799 |
| Class III | 2,891 |
| Not Yet Classified | 1 |
FDA Recall United States Terminated Historical recordClass I
ADM - CHICAGO
- Product
- Baker's Corner All Purpose Flour 5 lb. bag UPC code: 041…
- Reason
- potential presence of E. coli. O26
- Published
- July 24, 2019
- Distribution
- Nationwide
FDA Recall United States Terminated Historical recordClass II
Perrigo Company PLC
- Product
- Parent's Choice Advantage Infant Formula Milk-Based Powder w…
- Reason
- Product may contain metal fragments.
- Published
- July 24, 2019
- Distribution
- Nationwide
FDA Recall United States Terminated Historical recordClass III
Wilton Brands
- Product
- Wilton Chocolate decorator icing stiff consistency 16 oz…
- Reason
- Mold
- Published
- July 24, 2019
- Distribution
- AL AR AZ CA CO CT DE FL GA IA…
FDA Recall Terminated Historical recordClass II
Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories
- Reason
- GMP Deviations: Potential cross contamination due to cleaning procedure failure.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium Tablets, USP. 50 mg. NDC# 0904-6390-61. Rx only. 100 count Unit Dose Cartons. Manufactured by Major Pharmaceuticals 17177 N. Laurel Park Drive Suite 233, Livonia, MI 48152.
- Reason
- CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium, 50 mg tablets, 1000 count bottle, NDC 60429-317-10
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium andHydrochlorothiazide Tablets 100 mg/25 mg 90 tablets, USP Rx Only, Manufactured for: Macleods Pharma USA inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi, Himachal Pradesh, INDIA NDC 33342-052-10
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/12.5 mg 90 Tablets, USP Manufactured for: Macleods Pharma USA inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi, Himachal Pradesh, INDIA NDC 33342-051-10
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg 90 Tablets, USP Manufactured for: Macleods Pharma USA inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi, Himachal Pradesh, INDIA NDC 33342-050-10
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium Tablets 50 mg 1000 Tablets, USP Rx Only Manufactured for: Macleods Pharma USA inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi, Himachal Pradesh, INDIA NDC 33342-045-44
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Losartan Potassium Tablets, USP 50 mg 90 tablets Rx Only Manufactured for: Macleods Pharma USA inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi, Himachal Pradesh, INDIA NDC 33342-045-10
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
LOSARTAN POTASSIUM 100 mg TABLET BULK 90 count bottles, NDC 00591-3747-00
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
LOSARTAN POTASSIUM 50 mg TABLET BULK 90 count bottles and 1000 count bottles, NDC 00591-3746-00
- Reason
- CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
- Published
- July 17, 2019
- Distribution
- Nationwide
FDA Recall United States Terminated Historical recordClass II
Ziba Nut Incorporated
- Product
- OU Kosher Salted and Roasted Edamame Green Beans (Regular Sa…
- Reason
- Product does not declare soy. Allergen statement not printed on label of roasted and salted Edamame.
- Published
- July 17, 2019
- Distribution
- Multiple states
FDA Recall United States Terminated Historical recordClass III
Reily Foods Co., Inc
- Product
- Blue Plate Light Mayonnaise 30oz, PET jars
- Reason
- Yeast presence that resulted in gas formation causing bottles to bloat and release mayonnaise.
- Published
- July 17, 2019
- Distribution
- Distributed in the states of TN, Al, GA,…
FDA Recall United States Terminated Historical recordClass III
Reily Foods Co., Inc
- Product
- Blue Plate Light Olive Oil Mayonnaise 30oz / 18oz, PET jars…
- Reason
- Yeast presence that resulted in gas formation causing bottles to bloat and release mayonnaise.
- Published
- July 17, 2019
- Distribution
- Distributed in the states of TN, Al, GA,…
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
